Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-037/48
A61K-037/62
A61K-037/54
A61K-037/547
출원번호
US-0434953
(1995-05-04)
발명자
/ 주소
Sipos Tibor (Lebanon NJ)
출원인 / 주소
Digestive Care Inc. (Lebanon NJ 02)
인용정보
피인용 횟수 :
30인용 특허 :
5
초록▼
Disclosed are gastric acid-resistant polymer-coated, buffered digestive enzymes/ursodeoxycholate compositions, process for their preparations and methods for treating digestive disorders, pancreatic enzyme insufficiency, impaired liver function, and cystic fibrosis for regulating the absorption of d
Disclosed are gastric acid-resistant polymer-coated, buffered digestive enzymes/ursodeoxycholate compositions, process for their preparations and methods for treating digestive disorders, pancreatic enzyme insufficiency, impaired liver function, and cystic fibrosis for regulating the absorption of dietary iron and cholesterol, and for dissolving gallstones by administering the compositions to a mammal in need of such treatment.
대표청구항▼
A buffered digestive enzyme/bile salt composition for the treatment of digestive enzyme/bile salt deficiency of mammals comprising, by weight per weight percentages based on the total weight of the composition: a) from about 10 to about 90.0% of a concentrate of an enzyme selected from the group con
A buffered digestive enzyme/bile salt composition for the treatment of digestive enzyme/bile salt deficiency of mammals comprising, by weight per weight percentages based on the total weight of the composition: a) from about 10 to about 90.0% of a concentrate of an enzyme selected from the group consisting of pancreatic proteases, pancreatic lipases, pancreatic nucleases and pancreatic amylases; b) from about 0.3 to about 75% of a bile salt in powder form; c) from about 7.35 to about 40.50% of a buffering agent selected from the group consisting of anhydrous sodium carbonate, sodium bicarbonate, potassium carbonate, ammonium carbonate, tromethamine, di(tris(hydoxymethyl)aminomethane) carbonate, tris-glycine, di-arginine in the molecular weight range of 350 to 50,000 daltons, tri-arginine in the molecular weight range of 350 to 50,000 daltons, poly-arginine in the molecular weight range of 350 to 50,000 daltons, di-lysine in the molecular weight range of 290 to 15,000 daltons, tri-lysine in the molecular weight range of 290 to 15,000 daltons, poly-lysine in the molecular weight range of 290 to 15,000 daltons, diethylamine and triethanolamine; d) from about 0.9 to about 16% of a disintegrant selected from the group consisting of starch, modified starches, microcrystalline cellulose and propylene glycol alginate; e) from about 0.3 to about 15.0% of an adhesive polymer selected from the group consisting of hydroxypropyl cellulose, polyvinylpyrrolidone, cellulose acetate phthalate, methyl cellulose and propylene glycol alginate; and f) from about 7.0 to about 15% of an non-porous, gastric acid-resistant and pharmaceutically acceptable polymer-coating which contains from about 0.2 to about 2% talc and which is insoluble in the pH range of from about 1.5 to about 5 but is soluble in the pH range of from about 5.5 to about 9.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (5)
Pich Claus H. (Moorrege DEX) Moest Thomas (Moorrege DEX), Cylindrical microtablets.
Wischniewski Martin (Neustadt DEX) Feicho Lutz (Neustadt DEX) Fischer Gerhard (Hanover DEX) Peschke Guenter (Hanover DEX), Process for the production of pancreatin pellets.
Schuler, Christopher; Schuler, Edward; Penet, Christopher S.; Moore, Gregory; Gregory, Kelly, Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase.
Stillman, Suzanne Jaffe, Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s).
Schuler, Christopher; Schuler, Edward; Penet, Christopher S.; Gregory, Kelly; Moore, K. Gregory, Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.